As of Apr 2, 2025, the Healthequity stock's price-to-earnings ratio is 79.95. This results from the current EPS of $1.11 and stock price of $88.74. The current PE ratio is nearly equal to the average from the previous four quarters.
The PE ratio of Healthequity has averaged 609.52 over the last ten years. The current P/E ratio of 79.95 is 87% lower than the historical average. In the past ten years, HQY's PE ratio peaked in the Jul 2021 quarter at 7,398, when the stock price was $73.98 and the EPS was $0.01. The lowest point was in the Apr 2019 quarter, when it reached 45.17 with a price of $67.75 and an EPS of $1.5.
Maximum annual increase: 521.82% in 2021
Maximum annual decrease: -37.65% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2025 | 99.48 | -14.45% | $110.42 | $1.11 |
2024 | 116.28 | N/A | $75.58 | $0.65 |
2023 | N/A | N/A | $60.85 | -$0.31 |
2022 | N/A | N/A | $53.44 | -$0.53 |
2021 | 696.25 | 521.82% | $83.55 | $0.12 |
2020 | 111.97 | 115.53% | $66.06 | $0.59 |
2019 | 51.95 | -18.93% | $62.34 | $1.2 |
2018 | 64.08 | -37.65% | $50.62 | $0.79 |
2017 | 102.78 | 38.31% | $46.25 | $0.45 |
2016 | 74.31 | 39.52% | $21.55 | $0.29 |
2015 | 53.26 | N/A | $20.77 | $0.39 |
2014 | N/A | N/A | N/A | -$1.26 |
2013 | N/A | N/A | N/A | $0.81 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Jan 2025 | 99.48 | 30.69% | $110.42 | $1.11 |
Oct 2024 | 76.12 | 18.33% | $85.25 | $1.12 |
Jul 2024 | 64.33 | -24.18% | $78.48 | $1.22 |
Apr 2024 | 84.85 | -27.03% | $78.91 | $0.93 |
Jan 2024 | 116.28 | -44.84% | $75.58 | $0.65 |
Oct 2023 | 210.82 | -53.45% | $71.68 | $0.34 |
Jul 2023 | 452.93 | N/A | $67.94 | $0.15 |
Apr 2023 | N/A | N/A | $53.45 | -$0.1 |
Jan 2023 | N/A | N/A | $60.85 | -$0.31 |
Oct 2022 | N/A | N/A | $77.91 | -$0.7 |
Jul 2022 | N/A | N/A | $58.17 | -$0.74 |
Apr 2022 | N/A | N/A | $62.32 | -$0.66 |
Jan 2022 | N/A | N/A | $53.44 | -$0.53 |
Oct 2021 | N/A | N/A | $66.18 | -$0.07 |
Jul 2021 | 7,398 | 484.28% | $73.98 | $0.01 |
The current PE ratio of HQY is lower than the 3, 5 and 10-year averages.
In comparison to its peer stocks UHAL and EZPW, HQY's PE ratio is higher.
Stock name | PE ratio | Market cap |
---|---|---|
EZPW Ezcorp Inc | 9.99 | $861.44M |
UHAL Amerco | 30.76 | $12.73B |
HQY Healthequity Inc | 75.59 | $7.26B |
HQY's price to earnings ratio is 79.95 as of Apr 2, 2025.
Over the last 3 years, the average price to earnings ratio for HQY stock is 157.83.
Over the last 5 years, the average price to earnings ratio for HQY stock is 1484.05.
In the last ten years, the Jul 2021 quarter recorded the highest quarterly PE ratio at 7,398.
HQY's price to earnings ratio is currently 87% below its 10-year historical average.
HQY's PE ratio is high because the stock price is relatively expensive compared to the earnings generated by the company.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 2, 2025), Healthequity's stock price is $88.74. The earnings per share for the trailing twelve months (TTM) ending Jan 2025 is $1.11. Therefore, Healthequity's PE ratio for today is 79.95. PE RATIO(79.95) = STOCK PRICE($88.74) / TTM EPS($1.11)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.